Medical News

RSS

Young mothers see rapid increase in substance-related emergency department visits

Emergency department (ED) visits for use of substances, especially opioids, amphetamines, and cannabis, by mothers with dependent children increased almost 5% a year, in contrast to an increase of almost 2% a year among females without children, according to a large study in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.260078.

26 Oct 2026

Understanding the symptoms and treatments of pelvic organ prolapse

The pelvic floor is a layer of muscles and connective tissues that supports the uterus, bladder, urethra, vagina and rectum. The pelvic floor supports the organs in your pelvis from underneath, almost like a hammock.

26 Oct 2026

New poll shows which childhood vaccines US parents trust

While support for childhood vaccines is high, concerns about COVID-19 vaccine safety during pregnancy reveal significant public health messaging challenges.

26 Oct 2026

Study reveals a broad shift away from overtreatment of low-risk prostate cancer

An analysis of United States data reveals a broad shift away from overtreatment of low-risk prostate cancer.

26 Oct 2026

Clues to prostate cancer risk in blood samples taken 15 years earlier

Recent study links blood proteins to aggressive prostate cancer, identifying potential biomarkers for early risk prediction and insights into immune activity.

26 Oct 2026

New archiving technique reveals past gene activity in cells

Information on what a cell did a few hours or days ago is generally unavailable to researchers, who can only measure the cell's current status.

26 Oct 2026

Scientists discover a deep brain structure crucial for holding thoughts

Reading a sentence, following a conversation, solving a problem or deciding what to do next: all of these rely on working memory.

26 Oct 2026

Taking a GLP-1 drug? Here's what the safety evidence really shows

A review on GLP-1 receptor agonists highlights risks like pancreatitis and thyroid cancer, emphasizing individual patient risk over general safety concerns.

26 Oct 2026

One in three young adults turns to AI for substance use

More than 32% of participants in a Rutgers study reported using ChatGPT and similar chatbots for substance-use information.

26 Oct 2026

Geriatric chronic kidney disease patients benefit from SGLT2 inhibition

New research uncovers the potential benefits and risks of sodium-glucose cotransporter 2 (SGLT2) inhibitors for adults aged 80 years or older with chronic kidney disease (CKD). The findings will be presented at ASN Kidney Week 2026 October 22–25.

26 Oct 2026

Airborne ESKAPE bacteria pose severe risks to immunocompromised patients

At a clinic in South Africa, researchers have identified airborne ESKAPE bacteria which survive most antibiotic medicines. The clinic is in a densely populated inner-city area.

26 Oct 2026

Next generation KRAS inhibitor divarasib significantly extends lung cancer survival

Patients with previously treated advanced KRAS G12C-mutant non-small cell lung cancer (NSCLC) lived significantly longer and saw improved disease control when treated with the next-generation KRAS targeted therapy divarasib, according to researchers from The University of Texas MD Anderson Cancer Center.

26 Oct 2026

Phase 3 EMT2 trial demonstrates survival benefit for high-dose EPA

Patients assigned to receive high-dose eicosapentaenoic acid (EPA), an omega-3 fatty acid, before and after surgery for colorectal cancer liver metastases had longer overall survival than those assigned to receive placebo, according to results of the phase 3 EMT2 trial presented at the ESMO Congress 2026.

26 Oct 2026

Can happy feelings trigger eating too? Researchers explored both sides of emotional eating

Among 3,834 members of weight-management programs, greater recent weight loss was associated with less emotional eating, fewer food cravings, and better mood. Participants identified distraction, meal planning, healthier food swaps, and group support as helpful strategies, but the observational study could not establish whether these approaches caused weight loss.

25 Oct 2026

Beer, wine or spirits: A large study finds different mortality patterns for each

Researchers analyzed data from 340,924 UK Biobank participants and found that high total alcohol consumption was associated with greater all-cause, cardiovascular, and cancer mortality, while moderate consumption was linked to increased cancer mortality. Beer/cider and spirits showed associations with higher mortality across several outcomes, whereas low-to-moderate wine consumption was linked to lower mortality for certain outcomes, though the observational study cannot establish causation.

25 Oct 2026

Women in perimenopause report more anxiety than other menopausal groups

Researchers reviewed 21 studies involving 24,523 women and found that perimenopausal and postmenopausal women had higher odds of reporting anxiety symptoms than premenopausal women. Their meta-analysis of 15 studies found the highest odds during perimenopause, but the cross-sectional evidence cannot establish that menopause causes anxiety.

25 Oct 2026

Rome changed Iberia’s ancestry more than the migrations that followed

Researchers analyzed ancient DNA from 243 individuals who lived in Iberia between 100 and 800 CE, alongside data from 58 previously studied individuals, to examine how Roman rule and early medieval migrations affected population ancestry. They found substantial Eastern Mediterranean- and North African-related ancestry contributions during Roman times, while later migrations introduced Central-Northern European ancestry without widespread replacement of the Hispano-Roman population.

25 Oct 2026

Personalized mRNA cancer vaccine cuts melanoma recurrence risk when added to immunotherapy

Adding a personalized mRNA-based cancer vaccine to immunotherapy after surgery for high-risk melanoma reduced the risk of recurrence or death by 42%, according to results from the phase 3 INTerpath-001 trial presented at the ESMO Congress 2026.

24 Oct 2026

Abiraterone triplet therapy improves long-term survival in metastatic prostate cancer

Adding abiraterone to standard treatment provides a lasting survival benefit for men whose prostate cancer has already spread at diagnosis, reinforcing the value of early treatment intensification.

24 Oct 2026

Drug combination delivers promising survival gains in advanced endometrial cancer

An immunotherapy-based regimen combining durvalumab and the PARP inhibitor, olaparib, demonstrated encouraging long-term survival outcomes for patients with advanced or recurrent endometrial cancer, according to new trial results presented by researchers from The University of Texas MD Anderson Cancer Center.

24 Oct 2026

Medical News

Young mothers see rapid increase in substance-related emergency department visits

Understanding the symptoms and treatments of pelvic organ prolapse

New poll shows which childhood vaccines US parents trust

Study reveals a broad shift away from overtreatment of low-risk prostate cancer

Clues to prostate cancer risk in blood samples taken 15 years earlier

New archiving technique reveals past gene activity in cells

Scientists discover a deep brain structure crucial for holding thoughts

Taking a GLP-1 drug? Here's what the safety evidence really shows

One in three young adults turns to AI for substance use

Geriatric chronic kidney disease patients benefit from SGLT2 inhibition

Airborne ESKAPE bacteria pose severe risks to immunocompromised patients

Next generation KRAS inhibitor divarasib significantly extends lung cancer survival

Phase 3 EMT2 trial demonstrates survival benefit for high-dose EPA

Can happy feelings trigger eating too? Researchers explored both sides of emotional eating

Beer, wine or spirits: A large study finds different mortality patterns for each

Women in perimenopause report more anxiety than other menopausal groups

Rome changed Iberia’s ancestry more than the migrations that followed

Personalized mRNA cancer vaccine cuts melanoma recurrence risk when added to immunotherapy

Abiraterone triplet therapy improves long-term survival in metastatic prostate cancer

Drug combination delivers promising survival gains in advanced endometrial cancer

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

Latest News